| Anaphylaxis in children and adolescents: the European Anaphylaxis Registry LB Grabenhenrich, S Dölle, A Moneret-Vautrin, A Köhli, L Lange, ... Journal of allergy and clinical immunology 137 (4), 1128-1137. e1, 2016 | 604 | 2016 |
| GA2LEN skin test study I: GA2LEN harmonization of skin prick testing: novel sensitization patterns for inhalant allergens in Europe TZ L Heinzerling, G Burbach, G Edenharter, C Bachert, C Bindslev-Jensen, S ... Allergy 64 (10), 1498-1506, 2009 | 488 | 2009 |
| GA2LEN skin test study II: Clinical relevance of inhalant allergen sensitizations in Europe TZ G J Burbach, L M Heinzerling, C Bachert,........, E von Mutius, A Wiesner ... Allergy 64 (10), 1507-1515, 2009 | 378 | 2009 |
| Results from the 5-year SQ grass sublingual immunotherapy tablet asthma prevention (GAP) trial in children with grass pollen allergy E Valovirta, TH Petersen, T Piotrowska, MK Laursen, JS Andersen, ... Journal of Allergy and Clinical Immunology 141 (2), 529-538. e13, 2018 | 325 | 2018 |
| Symptom profile and risk factors of anaphylaxis in Central Europe M Worm, G Edenharter, F Rueff, K Scherer, C Pföhler, V Mahler, ... Allergy 67 (5), 691-698, 2012 | 252 | 2012 |
| Provoking allergens and treatment of anaphylaxis in children and adolescents–data from the anaphylaxis registry of German‐speaking countries S Hompes, A Köhli, K Nemat, K Scherer, L Lange, F Rueff, E Rietschel, ... Pediatric allergy and immunology 22 (6), 568-574, 2011 | 222 | 2011 |
| Factors increasing the risk for a severe reaction in anaphylaxis: An analysis of data from The European Anaphylaxis Registry M Worm, W Francuzik, JM Renaudin, MB Bilo, V Cardona, ... Allergy 73 (6), 1322-1330, 2018 | 221 | 2018 |
| Triggers and treatment of anaphylaxis: an analysis of 4000 cases from Germany, Austria and Switzerland M Worm, O Eckermann, S Dölle, W Aberer, K Beyer, T Hawranek, ... Deutsches Ärzteblatt International 111 (21), 367, 2014 | 217 | 2014 |
| Loss of abdominal fat and improvement of the cardiovascular risk profile by regular moderate exercise training in patients with NIDDM. SGA Lehmann R, Vokac-Wiesner A, Niedermann K, Agosti K Diabetologia 38 ((11)), 1313-9, 1995 | 205 | 1995 |
| GA2LEN skin test study III: Minimum battery of test inhalant allergens needed in epidemiological studies in patients TZ P.-J.Bousquet, G. Burbach, L.M. Heinzerling, ... P. Demoly , E von Mutius ... Allergy 64 (11), 1656-1662, 2009 | 139 | 2009 |
| Clinical relevance is associated with allergen‐specific wheal size in skin prick testing T Haahtela, GJ Burbach, C Bachert, C Bindslev‐Jensen, S Bonini, ... Clinical & Experimental Allergy 44 (3), 407-416, 2014 | 104 | 2014 |
| Epinephrine in Severe Allergic Reactions LB Grabenhenrich, S Dölle, F Ruëff, JM Renaudin, K Scherer, C Pföhler, ... J All Clin Imm Pract, 2018 | 99 | 2018 |
| CRIM-negative infantile Pompe disease: 42-month treatment outcome M Rohrbach, A Klein, A Köhli-Wiesner, D Veraguth, I Scheer, C Balmer, ... Journal of inherited metabolic disease 33, 751-757, 2010 | 98 | 2010 |
| Design and recruitment for the GAP trial, investigating the preventive effect on asthma development of an SQ-standardized grass allergy immunotherapy tablet in children with … E Valovirta, AKH Berstad, J de Blic, A Bufe, P Eng, S Halken, P Ojeda, ... Clinical therapeutics 33 (10), 1537-1546, 2011 | 92 | 2011 |
| Implementation of anaphylaxis management guidelines: a register-based study L Grabenhenrich, S Hompes, H Gough, F Ruëff, K Scherer, C Pföhler, ... PLOS one 7 (5), e35778, 2012 | 90 | 2012 |
| Peanut‐induced anaphylaxis in children and adolescents: data from the European Anaphylaxis Registry I Maris, S Dölle‐Bierke, JM Renaudin, L Lange, A Koehli, T Spindler, ... Allergy 76 (5), 1517-1527, 2021 | 45 | 2021 |
| Risk factors and characteristics of biphasic anaphylaxis M Kraft, KS Hofmeier, F Ruëff, C Pföhler, JM Renaudin, MB Bilò, ... The Journal of Allergy and Clinical Immunology: In Practice 8 (10), 3388 …, 2020 | 44 | 2020 |
| Erste daten der pilotphase des anaphylaxie-registers im deutsch-sprachigen raum S Hompes, J Kirschbaum, K Scherer, R Treudler, B Przybilla, M Henzgen, ... Allergo Journal 17 (7), 550-555, 2008 | 37 | 2008 |
| Benefits from the use of a pimecrolimus-based treatment in the management of atopic dermatitis in clinical practice. Analysis of a Swiss cohort. SD Simon D, Lubbe J, Wuthrich B, Wiesner A, Weber MM, Laffitte E, Anliker MD ... Dermatology 213 ((4):), 313-8, 2006 | 35 | 2006 |
| Induction of specific immunotherapy with hymenoptera venoms using ultrarush regimen in children: safety and tolerance A Köhli-Wiesner, L Stahlberger, C Bieli, T Stricker, R Lauener Journal of allergy 2012, 2012 | 25 | 2012 |
